Lider O - Search Results

1

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.

Achiron A, Margalit R, Hershkoviz R, Markovits D, Reshef T, Melamed E, Cohen IR, Lider O. Achiron A, et al. Among authors: lider o. J Clin Invest. 1994 Feb;93(2):600-5. doi: 10.1172/JCI117012. J Clin Invest. 1994. PMID: 8113397 Free PMC article.

2

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling.

Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR. Zanin-Zhorov A, et al. Among authors: lider o. J Clin Invest. 2006 Jul;116(7):2022-32. doi: 10.1172/JCI28423. Epub 2006 Jun 8. J Clin Invest. 2006. Retraction in: J Clin Invest. 2018 Jun 1;128(6):2651. doi: 10.1172/JCI121856. PMID: 16767222 Free PMC article. Retracted.

3

T cells in the spinal cord in experimental autoimmune encephalomyelitis are matrix adherent and secrete tumor necrosis factor alpha.

Hershkoviz R, Mor F, Gilat D, Cohen IR, Lider O. Hershkoviz R, et al. Among authors: lider o. J Neuroimmunol. 1992 Mar;37(1-2):161-6. doi: 10.1016/0165-5728(92)90167-j. J Neuroimmunol. 1992. PMID: 1372327

4

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.

Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR. Lider O, et al. Science. 1988 Jan 8;239(4836):181-3. doi: 10.1126/science.2447648. Science. 1988. PMID: 2447648

5

Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.

Lider O, Baharav E, Mekori YA, Miller T, Naparstek Y, Vlodavsky I, Cohen IR. Lider O, et al. J Clin Invest. 1989 Mar;83(3):752-6. doi: 10.1172/JCI113953. J Clin Invest. 1989. PMID: 2493485 Free PMC article.

Cell. Physiol. 118:169-176; Fridman, R., O. Lider, Y. Naparstek, Z. Fuks, I. Vlodavsky, and I. R. Cohen. 1987. J. Cell. Physiol. 130:85-92; Lider, O., J. ...We found previously that heparin molecules inhibited expression of T lymphocyte heparanase acti …

Cell. Physiol. 118:169-176; Fridman, R., O. Lider, Y. Naparstek, Z. Fuks, I. Vlodavsky, and I. R. Cohen. 1987. J. Cell. Physio …

6

A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.

Lider O, Cahalon L, Gilat D, Hershkoviz R, Siegel D, Margalit R, Shoseyov O, Cohen IR. Lider O, et al. Proc Natl Acad Sci U S A. 1995 May 23;92(11):5037-41. doi: 10.1073/pnas.92.11.5037. Proc Natl Acad Sci U S A. 1995. PMID: 7761444 Free PMC article.

7

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action.

Achiron A, Gilad R, Margalit R, Gabbay U, Sarova-Pinhas I, Cohen IR, Melamed E, Lider O, Noy S, Ziv I. Achiron A, et al. Among authors: lider o. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):57-61. doi: 10.1136/jnnp.57.suppl.57. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964856 Free PMC article.

8

Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.

Hershkoviz R, Mor F, Miao HQ, Vlodavsky I, Lider O. Hershkoviz R, et al. Among authors: lider o. J Autoimmun. 1995 Oct;8(5):741-50. doi: 10.1006/jaut.1995.0055. J Autoimmun. 1995. PMID: 8579728

9

Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents.

Cahalon L, Lider O, Schor H, Avron A, Gilat D, Hershkoviz R, Margalit R, Eshel A, Shoseyev O, Cohen IR. Cahalon L, et al. Among authors: lider o. Int Immunol. 1997 Oct;9(10):1517-22. doi: 10.1093/intimm/9.10.1517. Int Immunol. 1997. PMID: 9352356

10

Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines.

Zanin-Zhorov A, Bruck R, Tal G, Oren S, Aeed H, Hershkoviz R, Cohen IR, Lider O. Zanin-Zhorov A, et al. Among authors: lider o. J Immunol. 2005 Mar 15;174(6):3227-36. doi: 10.4049/jimmunol.174.6.3227. J Immunol. 2005. PMID: 15749853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters